Effect of an endothelin antagonist on hemodynamic responses to angiotensin II.
We determined changes in blood pressure, cardiac output, and total peripheral conductance evoked by intravenous infusions of angiotensin II (Ang II) in conscious, unrestrained normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) before and after pretreatment with bosentan, a nonselective endothelin antagonist. Blood pressure was recorded by radiotelemetry and cardiac output by ultrasonic transit-time flow probes. Bosentan per se failed to affect basal blood pressure and evoked only small changes in cardiac output and total peripheral conductance in both strains. The pressor effects of Ang II were exaggerated in SHR compared with WKY. Strikingly, bosentan pretreatment blunted the increases in blood pressure, the fall in cardiac output, and the decreases in conductance evoked by lower doses of Ang II but not higher doses of the peptide. This effect was observed in both rat strains but was more pronounced in SHR. These data suggest that endothelin contributes to the hemodynamic effects of Ang II in both SHR and WKY and that endothelin may contribute to the exaggerated pressor responsiveness of SHR to Ang II.
Department of Pharmacology, College of Medicine, University of Saskatchewan, Saskatoon, Canada.
S M
SM
Balakrishnan
H D
HD
Wang
V
V
Gopalakrishnan
T W
TW
Wilson
J R
JR
McNeill
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D000077300:Bosentan; D019332:Endothelin-1 / Q000037:antagonists & inhibitors*; D006439:Hemodynamics / Q000187:drug effects*; D008297:Male; D011311:Pressoreceptors / Q000187:drug effects; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D013045:Species Specificity; D013449:Sulfonamides / Q000494:pharmacology*
D019332:Endothelin-1; D013449:Sulfonamides; D000804:Angiotensin II; D000077300:Bosentan